High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.
about
Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support.High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administrationStage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer.Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience.Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.Incidence and prevention of nonhaematological toxicity of high-dose chemotherapy.Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients.
P2860
Q36134870-D679F4D1-CC7E-42FF-9D08-D9B66A81BC5CQ36136361-886BA1F5-B6AC-4548-84A4-F95E787721D4Q36138637-73594926-F6DB-49F1-B748-6BD46675748BQ36420168-BB89AEEC-CE71-41EA-B7A8-C53658BD1D42Q36619123-B3A7016A-6F75-4D72-BE26-C841E1ABDD57Q37340528-D97E4D29-663D-473C-B85C-DBE3D2F2DED2Q39215738-0765E1A9-AEEB-46BE-9A8F-676C6E8F1F0FQ40670211-C6902D0F-8587-4E41-BABB-8AAA00D88F6BQ43710385-AB4A0880-DD57-4497-8CC9-A824A4C60EFEQ47578597-C3E8B09E-447E-4DC0-99BA-9DB6129227E1
P2860
High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
High-dose carboplatin, thiotep ...... cancer: a practical approach.
@ast
High-dose carboplatin, thiotep ...... cancer: a practical approach.
@en
type
label
High-dose carboplatin, thiotep ...... cancer: a practical approach.
@ast
High-dose carboplatin, thiotep ...... cancer: a practical approach.
@en
prefLabel
High-dose carboplatin, thiotep ...... cancer: a practical approach.
@ast
High-dose carboplatin, thiotep ...... cancer: a practical approach.
@en
P2093
P2860
P356
P1476
High-dose carboplatin, thiotep ...... cancer: a practical approach.
@en
P2093
Holtkamp MJ
Nooijen WJ
Rodenhuis S
Rutgers EJ
Schorangel JH
Slaper-Cortenbach IC
van der Schoot CE
van der Wall E
P2860
P2888
P304
P356
10.1038/BJC.1995.165
P407
P577
1995-04-01T00:00:00Z
P5875
P6179
1021767113